Nymox Pharmaceutical Corp (NYMX) Posts Q3 Loss of 4c/Share

Nymox Pharmaceutical Corp (NASDAQ: NYMX) reported Q3 EPS of ($0.04), $0.02 better than the analyst estimate of ($0.06). Revenue for the quarter came in at $320 thousand versus the consensus estimate of $750 thousand.

For earnings history and earnings-related data on Nymox Pharmaceutical Corp (NYMX) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Jefferies sees a buying opportunity in this S&P 500 sector
• Azitra, Inc. (AZTR) Tops Q2 EPS by 54c
• Range Impact, Inc. (RNGE) Reports Q2 Loss of $0.02